He expressed clear frustration and said, “If anything, on the eve of the unofficial start to earnings season, they ...

Supporting his view, Cantor Fitzgerald analyst Troy Jensen, on July 2, initiated coverage on D-Wave Quantum with an Overweight rating and announced a price target of $20.

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Analysts expect the Greenwich, Connecticut-based company to report quarterly earnings at 45 cents per share, up from 44 cents ...

As of July 17, 2025, two stocks in the consumer staples sector could be flashing a real warning to investors who value ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the energy sector. Mizuho analyst ...

B of A Securities analyst Joshua Shanker maintained Progressive with a Buy and lowered the price target from $337 to $336. Keefe, Bruyette & Woods analyst Meyer Shields maintained the stock with a ...

Three big catalysts are gearing up to hit the markets at month’s end. Matt Maley is going live this Sunday at 1 PM ET to ...

Investors monitor shifting market dynamics and consumer behavior post-pandemic, with Sarat Sethi sticking with Johnson & Johnson amid a positive earnings report. Stephen Weiss picks iShares Bitcoin ...

M offers an annual dividend yield of 1.85% — $2.92 a year. Here's how investors can exploit the dividend yield to pocket $500 monthly.

After the market close on Wednesday, Sarepta Therapeutics introduced a strategic restructuring plan that involves focusing on high-value, high-impact programs and supporting long-term financials.

While most investors chase yesterday's headlines, Tim Melvin spots tomorrow's winners. See the exact system that found NVIDIA ...